Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 488 results from 1 sources
http://web.expasy.org/cellosaurus/CVCL_1698

Cite this IFO Cat# IFO50344, RRID:CVCL_1698
Organism: Homo sapiens
Disease: Astrocytoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated. Shown to be a Marcus derivative (PubMed=20143388). From: Memorial Sloan-Kettering Cancer Center; New York; USA. Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis. Discontinued: IFO; IFO50344.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_4020

Cite this RRID:CVCL_4020
Organism: Homo sapiens
Disease: Renal cell carcinoma
Category: Cancer cell line
Comment: From: Memorial Sloan-Kettering Cancer Center; New York; USA. Doubling time: 30 hours (PubMed=2386958).

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this BCRC Cat# 60027, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this NCBI_Iran Cat# C217, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this IZSLER Cat# BS TCL 25, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this JCRB Cat# JCRB0085, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this RCB Cat# RCB0041, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this CLS Cat# 300209/p671_HL-60, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this DSMZ Cat# ACC-3, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this ATCC Cat# CCL-240, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this ECACC Cat# 98070106, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this KCB Cat# KCB 2014051YJ, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this BCRJ Cat# 0104, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this ICLC Cat# HTL95010, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this RCB Cat# RCB3683, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this TKG Cat# TKG 0345, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this IFO Cat# IFO50022, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0002

Cite this KCLB Cat# 10240, RRID:CVCL_0002
Organism: Homo sapiens
Disease: Adult acute myeloid leukemia
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Part of: MD Anderson Cell Lines Project. Part of: MYC genetic alteration cell panel (ATCC TCP-1035). Registration: National Institute of Standards and Technology, Standard Reference Materials; SRM 2392-I. Biotechnology: Used a source of mitochondrial DNA for USA forensic testing. Doubling time: 28 hours (PubMed=25984343); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for CDKN2A p.Arg80Ter (PubMed=17088437). Sequence variation: Heterozygous for NRAS p.Gln61Leu (PubMed=17088437). Omics: Cell surface proteome. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: Mitochondrial genome sequenced. Omics: N-glycan profiling. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Misspelling: Occasionally 'IIL-60'.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0004

Cite this CCLV Cat# CCLV-RIE 0439, RRID:CVCL_0004
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'K-652' in Cosmic 1523829. Misspelling: 'K652' in Cosmic 1516632 and Cosmic 2024372.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0004

Cite this RCB Cat# RCB1897, RRID:CVCL_0004
Organism: Homo sapiens
Disease: Chronic myelogenous leukemia, BCR-ABL1 positive
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 1. Part of: MD Anderson Cell Lines Project. Part of: NCI60 cancer cell line panel. Doubling time: 47 hours (PubMed=25984343); 19.6 hours (NCI-DTP); ~30-40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger). Sequence variation: Homozygous for TP53 p.Gln136fs*13 (PubMed=17088437; PubMed=18277095). Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K27me3 ChIP-seq epigenome analysis. Omics: H3K36me3 ChIP-seq epigenome analysis. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'K-652' in Cosmic 1523829. Misspelling: 'K652' in Cosmic 1516632 and Cosmic 2024372.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X